Global In situ Hybridization Market Size, Status and Forecast 2020-2026

In situ hybridization (ISH) is a type of hybridization that uses a labeled complementary DNA, RNA or modified nucleic acids strand to localize a specific DNA or RNA sequence in a portion or section of tissue (in situ), or, if the tissue is small enough, in the entire tissue, in cells, and in circulating tumor cells (CTCs). This is distinct from immunohistochemistry, which usually localizes proteins in tissue sections.
North America is expected to account for the largest share of the market in 2018. This can be attributed to growing clinical and research in cancer by biotechnology and pharmaceutical companies, government initiatives, increasing prevalence and diagnosis of cancer in the U.S. and Canada, and increasing adoption of companion diagnostics. Increased adoption of companion diagnostics is attributed to the development and launch of newer therapeutic agents. However, the Asia-Pacific region is expected to grow at the highest CAGR during the forecast period. This can be attributed to the growing presence of international players in China and India, increasing cancer prevalence and diagnosis, and increased healthcare expenditure across the Asia-Pacific region are drivers for the in situ hybridization market in this region.
Market Analysis and Insights: Global In situ Hybridization Market
In 2019, the global In situ Hybridization market size was US$ 542.8 million and it is expected to reach US$ 682.5 million by the end of 2026, with a CAGR of 3.3% during 2021-2026.
Global In situ Hybridization Scope and Market Size
In situ Hybridization market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global In situ Hybridization market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the In situ Hybridization market is segmented into Fluorescence In Situ Hybridization (FISH), Chromogenic In Situ Hybridization, etc.
Segment by Application, the In situ Hybridization market is segmented into Cancer Diagnosis, Immunology, Neuroscience, Cytology, Infectious Diseases, etc.
Regional and Country-level Analysis
The In situ Hybridization market is analysed and market size information is provided by regions (countries).
The key regions covered in the In situ Hybridization market report are North America, Europe, China, Japan, Southeast Asia, India and Central & South America, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.

Competitive Landscape

and In situ Hybridization Market Share Analysis
In situ Hybridization market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in In situ Hybridization business, the date to enter into the In situ Hybridization market, In situ Hybridization product introduction, recent developments, etc.
The major vendors include Abbott Laboratories, Roche, Thermo Fisher Scientific, Merck, Agilent Technologies, Perkin Elmer, Danaher, Exiqon, Biogenex Laboratories, Advanced Cell Diagnostics, Bio Sb, etc.

This report focuses on the global In situ Hybridization status, future forecast, growth opportunity, key market and key players. The study objectives are to present the In situ Hybridization development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

Abbott Laboratories
Roche
Thermo Fisher Scientific
Merck
Agilent Technologies
Perkin Elmer
Danaher
Exiqon
Biogenex Laboratories
Advanced Cell Diagnostics
Bio Sb

Market segment by Type, the product can be split into

Fluorescence In Situ Hybridization (FISH)
Chromogenic In Situ Hybridization

Market segment by Application, split into

Cancer Diagnosis
Immunology
Neuroscience
Cytology
Infectious Diseases

Market segment by Regions/Countries, this report covers

North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:

To analyze global In situ Hybridization status, future forecast, growth opportunity, key market and key players.
To present the In situ Hybridization development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of In situ Hybridization are as follows:
History Year: 2015-2019

Base Year:

2019

Estimated Year:

2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Frequently Asked Questions